Immediate Impact

52 standout
Sub-graph 1 of 21

Citing Papers

Frailty in Older Adults
2024 Standout
Therapeutic advances in rheumatoid arthritis
2024 Standout
2 intermediate papers

Works of Dan Henrohn being referenced

SAT0139 AGE-BASED (<65 VS ≥65 YEARS) INCIDENCE OF INFECTIONS AND SERIOUS INFECTIONS IN TOFACITINIB-, ADALIMUMAB- AND PLACEBO-TREATED PATIENTS WITH RHEUMATOID ARTHRITIS: A POST HOC ANALYSIS OF PHASE 2, PHASE 3 AND PHASE 3B/4 TOFACITINIB STUDIES
2020
Effects of Pharmacists' Interventions on Appropriateness of Prescribing and Evaluation of the Instruments' (MAI, STOPP and STARTs') Ability to Predict Hospitalization–Analyses from a Randomized Controlled Trial
2013

Author Peers

Author Last Decade Papers Cites
Dan Henrohn 81 155 57 499 185 26 743
Jack Twersky 79 86 63 302 58 32 893
H. Hamilton 175 59 13 365 50 10 836
Marisa Battistella 92 263 33 170 85 71 865
Mark Makowsky 59 105 18 378 104 37 904
Stephan Kr henb hl 30 103 10 490 213 11 894
John D. Voss 68 55 38 115 86 25 938
Linda Bryant 62 89 58 334 52 26 733
Brandon Brown 13 130 5 522 235 8 686
Mio Sakuma 71 179 105 261 178 60 854
Rishi Sikka 49 122 36 131 42 21 976

All Works

Loading papers...

Rankless by CCL
2026